Home › Proteinuria › Massachusetts › Boston
Proteinuria clinical trials in Boston, MA
3 studies for Proteinuria are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- Brigham and Womens Hosp Harvard Med School, Boston
Sparsentan for the Treatment of VEGF Signaling Pathway Inhibitor-Associated Proteinuria
RecruitingPhase 1
- Brigham and Women's Hospital, Boston
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
RecruitingPhase 3
- Massachusetts General Hospital, Boston
- Boston Univ School of Medicine, Boston
Proteinuria trials in other cities
- Houston, TX5 studies
- Aurora, CO5 studies
- Miami, FL4 studies
- Los Angeles, CA3 studies
- Orlando, FL3 studies
- Salt Lake City, UT3 studies
- Cedar Rapids, IA3 studies
- Philadelphia, PA3 studies
- Washington, DC3 studies
Other studies in Boston
- Breast Cancer110 studies
- Non-Small Cell Lung Cancer89 studies
- Cancer (all types)86 studies
- Metastatic Cancer63 studies
- Colorectal Cancer63 studies
- Lung Cancer62 studies
- Ovarian Cancer61 studies
- Prostate Cancer61 studies
- Depression51 studies
- Endometrial Cancer50 studies
- Acute Myeloid Leukemia45 studies
- Pancreatic Cancer44 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.